BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Topics
» Gastrointestinal, BioWorld Science
Gastrointestinal, BioWorld Science
RSS
Heptazyme, an exciting new approach to chronic hepatitis C, covered at AASLD
Nov. 7, 2000
AASLD news: optimal phase III anti-HBV dose of Coviracil selected from phase I/II data
Nov. 7, 2000
SAR leading to APC-2059, a potent and selective human mast cell tryptase inhibitor
Nov. 7, 2000
Antiviral agents for hepatitis emerge from R&D at CSIRO
Nov. 6, 2000
AASLD news: F-180 displays beneficial effects in portal hypertension-related bleeding
Nov. 6, 2000
Clevudine phase I trial results presented at AASLD meeting
Nov. 6, 2000
Combination therapy including Maxamine proves effective and safe in chronic HCV
Nov. 6, 2000
Clinical results for entecavir presented at AASLD meeting
Nov. 3, 2000
First combination monoclonal antibody therapy for chronic HBV shows promise in phase I
Nov. 3, 2000
InKine selects tradenames for CBP-1011
Oct. 31, 2000
Previous
1
2
…
550
551
552
553
554
555
556
557
558
…
673
674
Next